Health care regulatory lawyers Sung Park and Tom Greeson discuss why AI and machine learning-enabled medical devices have been so widespread in radiology.
They cover FDA's recent approvals, a new CMS time-limited add-on payment for an AI radiology product, and the potential legal implications of using these technologies in practice.
This article is presented for informational purposes only and is not intended to constitute legal advice.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
This article is presented for informational purposes only and is not intended to constitute legal advice.










